You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency

Article metrics

Article menu

Download PDFPDF

XML
Case report
Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2026

AbstractFullPdf
Jul 2020274274125
Aug 202017417437
Sep 202016216229
Oct 202012412450
Nov 2020646622
Dec 2020808031
Jan 2021535318
Feb 2021535330
Mar 2021515126
Apr 2021404015
May 2021323218
Jun 2021282811
Jul 2021343419
Aug 2021292915
Sep 2021393920
Oct 2021333330
Nov 2021343430
Dec 2021444419
Jan 2022373817
Feb 202232338
Mar 2022343417
Apr 202235367
May 2022434414
Jun 2022515213
Jul 2022333410
Aug 2022404021
Sep 2022323327
Oct 2022343621
Nov 202219198
Dec 202222227
Jan 2023191910
Feb 202336375
Mar 2023222316
Apr 2023232314
May 202321217
Jun 202318186
Jul 2023262611
Aug 2023333311
Sep 202324256
Oct 2023252512
Nov 2023282917
Dec 2023262621
Jan 2024293026
Feb 2024232314
Mar 2024151695
Apr 2024191926
May 2024181920
Jun 2024323217
Jul 2024586021
Aug 2024202012
Sep 2024131416
Oct 2024282820
Nov 2024282917
Dec 2024191919
Jan 2025353623
Feb 2025201924
Mar 2025343748
Apr 2025515162
May 2025252594
Jun 2025222224
Jul 2025110
Dec 2025100
Feb 2026100
Total255325761429